Claritev Corp. (CTEV)
39.39
+0.61
(+1.57%)
USD |
NYSE |
Aug 28, 16:00
39.37
-0.02
(-0.05%)
After-Hours: 20:00
Claritev Free Cash Flow : -17.92M for June 30, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -17.92M |
| March 31, 2026 | -31.63M |
| December 31, 2025 | -12.28M |
| September 30, 2025 | -113.12M |
| June 30, 2025 | -55.63M |
| March 31, 2025 | -103.48M |
| December 31, 2024 | -11.12M |
| September 30, 2024 | 49.70M |
| June 30, 2024 | 58.26M |
| March 31, 2024 | 40.93M |
| December 31, 2023 | 62.87M |
| September 30, 2023 | 68.67M |
| Date | Value |
|---|---|
| June 30, 2023 | 107.19M |
| March 31, 2023 | 153.26M |
| December 31, 2022 | 282.63M |
| September 30, 2022 | 286.34M |
| June 30, 2022 | 344.74M |
| March 31, 2022 | 337.79M |
| December 31, 2021 | 320.10M |
| September 30, 2021 | 337.81M |
| June 30, 2021 | 317.16M |
| March 31, 2021 | 329.30M |
| December 31, 2020 | 306.56M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| LataMed AI Corp. | -0.2553M |
| SCWorx Corp. | -0.9143M |
| Health Catalyst, Inc. | 6.551M |
| GoodRx Holdings, Inc. | 131.70M |
| iSpecimen, Inc. | -8.704M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 92.67M |
| Cash from Investing (Quarterly) | -38.08M |
| Cash from Financing (Quarterly) | -61.64M |
| Free Cash Flow Per Share (Quarterly) | 3.218 |
| Free Cash Flow to Equity (Quarterly) | 96.74M |
| Free Cash Flow to Firm (Quarterly) | 130.62M |
| Free Cash Flow Yield | -2.73% |